Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 28, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012983.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
zinc finger, SWIM-type containing 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
zinc finger, SWIM-type containing 7, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
zinc finger SWIM domain-containing protein 7 isoform X3
zinc finger SWIM domain-containing protein 7 isoform X1
zinc finger, SWIM-type containing 7, transcript variant X2
zinc finger SWIM domain-containing protein 7 isoform X2
translocase of inner mitochondrial membrane 22 homolog (yeast)
mitochondrial import inner membrane translocase subunit Tim22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 68% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
SET and MYND domain-containing protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
active breakpoint cluster region-related protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
polymerase (DNA-directed), delta interacting protein 2
SMG6 nonsense mediated mRNA decay factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
pre-rRNA-processing protein TSR1 homolog
solute carrier family 13 member 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
solute carrier family 13 member 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
solute carrier family 13 member 2-like isoform X2
solute carrier family 13 member 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 31
ribosomal protein S6 kinase-related protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ribosomal protein S6 kinase-related protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ribosomal protein S6 kinase-related protein-like isoform X2
ribosomal protein S6 kinase-related protein-like isoform X1
ribosomal protein S6 kinase-related protein-like, transcript variant X3
ribosomal protein S6 kinase-related protein-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Era-like 12S mitochondrial rRNA chaperone 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Era-like 12S mitochondrial rRNA chaperone 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
transient receptor potential cation channel subfamily V member 3-like
family with sequence similarity 222 member Ba, transcript variant X1
family with sequence similarity 222 member Ba, transcript variant X2
ER membrane protein complex subunit 6, transcript variant X2
ER membrane protein complex subunit 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transient receptor potential cation channel, subfamily V, member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel subfamily V member 1
inositol polyphosphate 5-phosphatase K-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
tricarboxylate transport protein, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol transfer protein alpha isoform-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
phosphatidylinositol transfer protein alpha isoform-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phosphatidylinositol transfer protein alpha isoform-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphatidylinositol transfer protein alpha isoform-like isoform X2
phosphatidylinositol transfer protein alpha isoform-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phosphatidylinositol transfer protein alpha isoform-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
phosphatidylinositol transfer protein alpha isoform-like, transcript variant X6
phosphatidylinositol transfer protein alpha isoform-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
phosphatidylinositol transfer protein alpha isoform-like isoform X1
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide 1, transcript variant X1
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide 1, transcript variant X2
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide 1 isoform X1
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide 1 isoform X2
v-crk avian sarcoma virus CT10 oncogene homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC122563880, transcript variant X1
uncharacterized LOC122563880, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
leucine-rich repeat-containing protein 75A
phosphatidylinositol glycan anchor biosynthesis, class S
unc-119 homolog a (C. elegans), transcript variant X2
unc-119 homolog a (C. elegans), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BCAS3 microtubule associated cell migration factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BCAS3 microtubule associated cell migration factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
BCAS3 microtubule associated cell migration factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
breast carcinoma-amplified sequence 3 isoform X1
breast carcinoma-amplified sequence 3 isoform X2
breast carcinoma-amplified sequence 3 isoform X3
uncharacterized LOC122563889, transcript variant X2
uncharacterized LOC122563889, transcript variant X1
uncharacterized LOC122563889, transcript variant X3
T-box transcription factor 2b, transcript variant X1
T-box transcription factor 2b, transcript variant X2
T-box transcription factor TBX2b isoform X1
T-box transcription factor TBX2b isoform X2
uncharacterized LOC122563892, transcript variant X1
uncharacterized LOC122563892, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
BRCA1 interacting helicase 1, transcript variant X2
BRCA1 interacting helicase 1, transcript variant X1
BRCA1 interacting helicase 1, transcript variant X3
Fanconi anemia group J protein isoform X1
Fanconi anemia group J protein isoform X2
integrator complex subunit 2, transcript variant X1
integrator complex subunit 2, transcript variant X4
integrator complex subunit 2, transcript variant X3
integrator complex subunit 2, transcript variant X2
mediator complex subunit 13a, transcript variant X2
mediator complex subunit 13a, transcript variant X1
mediator of RNA polymerase II transcription subunit 13a isoform X2
mediator of RNA polymerase II transcription subunit 13a isoform X1
mediator complex subunit 13a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 13a isoform X3
uncharacterized LOC122563897, transcript variant X1
uncharacterized protein LOC122563897 isoform X1
uncharacterized LOC122563897, transcript variant X2
uncharacterized protein LOC122563897 isoform X2
uncharacterized LOC122563898, transcript variant X4
uncharacterized LOC122563898, transcript variant X3
uncharacterized LOC122563898, transcript variant X1
uncharacterized protein LOC122563898 isoform X4
uncharacterized protein LOC122563898 isoform X3
uncharacterized protein LOC122563898 isoform X1
uncharacterized LOC122563898, transcript variant X2
uncharacterized protein LOC122563898 isoform X2
uncharacterized LOC122563898, transcript variant X5
uncharacterized protein LOC122563898 isoform X5
ribosomal protein S6 kinase b, polypeptide 1a, transcript variant X1
ribosomal protein S6 kinase b, polypeptide 1a, transcript variant X2
ribosomal protein S6 kinase b, polypeptide 1a, transcript variant X3
ribosomal protein S6 kinase b, polypeptide 1a, transcript variant X4
ribosomal protein S6 kinase beta-1 isoform X1
ribosomal protein S6 kinase beta-1 isoform X2
ribosomal protein S6 kinase beta-1 isoform X3
ribosomal protein S6 kinase beta-1 isoform X4
uncharacterized LOC122563903, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122563903, transcript variant X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122563903, transcript variant X3
vacuole membrane protein 1, transcript variant X5
vacuole membrane protein 1, transcript variant X1
vacuole membrane protein 1, transcript variant X2
vacuole membrane protein 1, transcript variant X4
vacuole membrane protein 1, transcript variant X3
peptidyl-tRNA hydrolase 2, mitochondrial
clathrin heavy chain 1, transcript variant X4
clathrin heavy chain 1, transcript variant X2
clathrin heavy chain 1, transcript variant X3
clathrin heavy chain 1, transcript variant X1
DEAH (Asp-Glu-Ala-His) box polypeptide 40, transcript variant X3
DEAH (Asp-Glu-Ala-His) box polypeptide 40, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
DEAH (Asp-Glu-Ala-His) box polypeptide 40, transcript variant X2
DEAH (Asp-Glu-Ala-His) box polypeptide 40, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DEAH (Asp-Glu-Ala-His) box polypeptide 40, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DEAH (Asp-Glu-Ala-His) box polypeptide 40, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
probable ATP-dependent RNA helicase DHX40 isoform X3
probable ATP-dependent RNA helicase DHX40 isoform X1
probable ATP-dependent RNA helicase DHX40 isoform X2
probable ATP-dependent RNA helicase DHX40 isoform X4
probable ATP-dependent RNA helicase DHX40 isoform X5
probable ATP-dependent RNA helicase DHX40 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
glycerophosphodiester phosphodiesterase domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
SMG8 nonsense mediated mRNA decay factor
spindle and kinetochore associated complex subunit 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
spindle and kinetochore associated complex subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
spindle and kinetochore associated complex subunit 2, transcript variant X1
spindle and kinetochore-associated protein 2 isoform X1
spindle and kinetochore associated complex subunit 2, transcript variant X4
spindle and kinetochore-associated protein 2 isoform X2
inactive serine/threonine-protein kinase TEX14-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
DNA repair protein RAD51 homolog 3 isoform X1
DNA repair protein RAD51 homolog 3 isoform X2
DNA repair protein RAD51 homolog 3 isoform X4
DNA repair protein RAD51 homolog 3 isoform X3
DNA repair protein RAD51 homolog 3 isoform X5
protein phosphatase, Mg2+/Mn2+ dependent, 1E
tripartite motif containing 37, transcript variant X3
tripartite motif containing 37, transcript variant X1
tripartite motif containing 37, transcript variant X2
E3 ubiquitin-protein ligase TRIM37 isoform X2
E3 ubiquitin-protein ligase TRIM37 isoform X1
OVCA2 serine hydrolase domain containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
OVCA2 serine hydrolase domain containing, transcript variant X1
2-(3-amino-3-carboxypropyl)histidine synthase subunit 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
uncharacterized LOC122563920, transcript variant X2
uncharacterized LOC122563920, transcript variant X1
replication protein A 70 kDa DNA-binding subunit
heparin cofactor 2-like, transcript variant X2
heparin cofactor 2-like, transcript variant X1
aldehyde dehydrogenase family 3 member A2-like, transcript variant X4
aldehyde dehydrogenase family 3 member A2-like, transcript variant X3
aldehyde dehydrogenase family 3 member A2-like, transcript variant X1
aldehyde dehydrogenase family 3 member A2-like, transcript variant X2
aldehyde dehydrogenase family 3 member A2-like
unc-51 like autophagy activating kinase 2, transcript variant X1
unc-51 like autophagy activating kinase 2, transcript variant X2
unc-51 like autophagy activating kinase 2, transcript variant X11
unc-51 like autophagy activating kinase 2, transcript variant X7
unc-51 like autophagy activating kinase 2, transcript variant X9
unc-51 like autophagy activating kinase 2, transcript variant X3
unc-51 like autophagy activating kinase 2, transcript variant X8
unc-51 like autophagy activating kinase 2, transcript variant X5
unc-51 like autophagy activating kinase 2, transcript variant X4
unc-51 like autophagy activating kinase 2, transcript variant X12
unc-51 like autophagy activating kinase 2, transcript variant X6
serine/threonine-protein kinase ULK2 isoform X2
serine/threonine-protein kinase ULK2 isoform X1
serine/threonine-protein kinase ULK2 isoform X7
serine/threonine-protein kinase ULK2 isoform X6
serine/threonine-protein kinase ULK2 isoform X3
serine/threonine-protein kinase ULK2 isoform X8
serine/threonine-protein kinase ULK2 isoform X10
serine/threonine-protein kinase ULK2 isoform X11
serine/threonine-protein kinase ULK2 isoform X4
serine/threonine-protein kinase ULK2 isoform X5
unc-51 like autophagy activating kinase 2, transcript variant X10
serine/threonine-protein kinase ULK2 isoform X9
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X3
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X2
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X1
aldehyde dehydrogenase, dimeric NADP-preferring-like
multidrug and toxin extrusion protein 1-like, transcript variant X1
multidrug and toxin extrusion protein 2-like isoform X1
multidrug and toxin extrusion protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
multidrug and toxin extrusion protein 1-like isoform X2
multidrug and toxin extrusion protein 2-like
multidrug and toxin extrusion protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122563934, transcript variant X2
uncharacterized LOC122563934, transcript variant X1
uncharacterized LOC122563934, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
rRNA methyltransferase 3A, mitochondrial
28S ribosomal protein S23, mitochondrial
musashi RNA-binding protein 2b, transcript variant X5
musashi RNA-binding protein 2b, transcript variant X10
musashi RNA-binding protein 2b, transcript variant X9
musashi RNA-binding protein 2b, transcript variant X12
musashi RNA-binding protein 2b, transcript variant X7
musashi RNA-binding protein 2b, transcript variant X6
musashi RNA-binding protein 2b, transcript variant X3
musashi RNA-binding protein 2b, transcript variant X4
musashi RNA-binding protein 2b, transcript variant X2
musashi RNA-binding protein 2b, transcript variant X1
musashi RNA-binding protein 2b, transcript variant X16
musashi RNA-binding protein 2b, transcript variant X25
musashi RNA-binding protein 2b, transcript variant X27
musashi RNA-binding protein 2b, transcript variant X23
musashi RNA-binding protein 2b, transcript variant X19
musashi RNA-binding protein 2b, transcript variant X17
musashi RNA-binding protein 2b, transcript variant X14
musashi RNA-binding protein 2b, transcript variant X11
musashi RNA-binding protein 2b, transcript variant X24
musashi RNA-binding protein 2b, transcript variant X20
musashi RNA-binding protein 2b, transcript variant X26
musashi RNA-binding protein 2b, transcript variant X18
musashi RNA-binding protein 2b, transcript variant X15
musashi RNA-binding protein 2b, transcript variant X13
musashi RNA-binding protein 2b, transcript variant X21
musashi RNA-binding protein 2b, transcript variant X8
musashi RNA-binding protein 2b, transcript variant X22
RNA-binding protein Musashi homolog 2b isoform X21
RNA-binding protein Musashi homolog 2b isoform X27
RNA-binding protein Musashi homolog 2b isoform X26
RNA-binding protein Musashi homolog 2b isoform X12
RNA-binding protein Musashi homolog 2b isoform X2
RNA-binding protein Musashi homolog 2b isoform X25
RNA-binding protein Musashi homolog 2b isoform X23
RNA-binding protein Musashi homolog 2b isoform X19
RNA-binding protein Musashi homolog 2b isoform X17
RNA-binding protein Musashi homolog 2b isoform X14
RNA-binding protein Musashi homolog 2b isoform X11
RNA-binding protein Musashi homolog 2b isoform X5
RNA-binding protein Musashi homolog 2b isoform X24
RNA-binding protein Musashi homolog 2b isoform X20
RNA-binding protein Musashi homolog 2b isoform X18
RNA-binding protein Musashi homolog 2b isoform X15
RNA-binding protein Musashi homolog 2b isoform X13
RNA-binding protein Musashi homolog 2b isoform X10
RNA-binding protein Musashi homolog 2b isoform X9
RNA-binding protein Musashi homolog 2b isoform X8
RNA-binding protein Musashi homolog 2b isoform X7
RNA-binding protein Musashi homolog 2b isoform X6
RNA-binding protein Musashi homolog 2b isoform X3
RNA-binding protein Musashi homolog 2b isoform X4
RNA-binding protein Musashi homolog 2b isoform X1
RNA-binding protein Musashi homolog 2b isoform X16
RNA-binding protein Musashi homolog 2b isoform X22
musashi RNA-binding protein 2b, transcript variant X28
RNA-binding protein Musashi homolog 2b isoform X28
uncharacterized LOC122563818, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122563818, transcript variant X1
neurofibromin 1a, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
WD repeat and SOCS box containing 1, transcript variant X1
WD repeat and SOCS box containing 1, transcript variant X2
WD repeat and SOCS box-containing protein 1 isoform X2
WD repeat and SOCS box-containing protein 1 isoform X1
kinase suppressor of ras 1a, transcript variant X3
kinase suppressor of ras 1a, transcript variant X4
kinase suppressor of ras 1a, transcript variant X5
kinase suppressor of ras 1a, transcript variant X6
kinase suppressor of ras 1a, transcript variant X7
kinase suppressor of ras 1a, transcript variant X1
kinase suppressor of ras 1a, transcript variant X9
kinase suppressor of ras 1a, transcript variant X2
kinase suppressor of ras 1a, transcript variant X10
kinase suppressor of ras 1a, transcript variant X12
kinase suppressor of ras 1a, transcript variant X11
kinase suppressor of ras 1a, transcript variant X8
lectin, galactoside-binding, soluble, 9 (galectin 9)-like 1
LYR motif containing 9, transcript variant X3
LYR motif containing 9, transcript variant X5
LYR motif containing 9, transcript variant X1
LYR motif containing 9, transcript variant X2
LYR motif containing 9, transcript variant X4
intraflagellar transport 20 homolog (Chlamydomonas), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
intraflagellar transport 20 homolog (Chlamydomonas), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
intraflagellar transport protein 20 homolog
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2, transcript variant X1
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2, transcript variant X4
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 isoform X2
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2, transcript variant X2
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2, transcript variant X3
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 isoform X1
small G protein signaling modulator 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
small G protein signaling modulator 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
small G protein signaling modulator 2 isoform X1
small G protein signaling modulator 2 isoform X2
MAX network transcriptional repressor a, transcript variant X2
MAX network transcriptional repressor a, transcript variant X1
MAX network transcriptional repressor a, transcript variant X3
methyltransferase 16, N6-methyladenosin, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
methyltransferase 16, N6-methyladenosin, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
RNA N6-adenosine-methyltransferase mettl16 isoform X4
RNA N6-adenosine-methyltransferase mettl16 isoform X3
methyltransferase 16, N6-methyladenosin, transcript variant X5
methyltransferase 16, N6-methyladenosin, transcript variant X3
methyltransferase 16, N6-methyladenosin, transcript variant X4
methyltransferase 16, N6-methyladenosin, transcript variant X2
methyltransferase 16, N6-methyladenosin, transcript variant X1
methyltransferase 16, N6-methyladenosin, transcript variant X8
RNA N6-adenosine-methyltransferase mettl16 isoform X5
RNA N6-adenosine-methyltransferase mettl16 isoform X1
RNA N6-adenosine-methyltransferase mettl16 isoform X2
lissencephaly-1 homolog, transcript variant X3
lissencephaly-1 homolog, transcript variant X2
lissencephaly-1 homolog, transcript variant X4
lissencephaly-1 homolog, transcript variant X1
platelet-activating factor acetylhydrolase IB subunit beta isoform X1
clustered mitochondria (cluA/CLU1) homolog a, transcript variant X3
clustered mitochondria (cluA/CLU1) homolog a, transcript variant X4
clustered mitochondria (cluA/CLU1) homolog a, transcript variant X2
clustered mitochondria (cluA/CLU1) homolog a, transcript variant X1
clustered mitochondria protein homolog isoform X3
clustered mitochondria protein homolog isoform X2
clustered mitochondria protein homolog isoform X1
clustered mitochondria protein homolog isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
A kinase (PRKA) anchor protein 10, transcript variant X1
A kinase (PRKA) anchor protein 10, transcript variant X2
A-kinase anchor protein 10, mitochondrial isoform X2
A-kinase anchor protein 10, mitochondrial isoform X1
coiled-coil domain containing 92Ba, transcript variant X1
coiled-coil domain containing 92Ba, transcript variant X4
coiled-coil domain containing 92Ba, transcript variant X2
coiled-coil domain containing 92Ba, transcript variant X3
coiled-coil domain-containing protein 92
RAP1 GTPase activating protein 2a, transcript variant X1
rap1 GTPase-activating protein 2a isoform X1
RAP1 GTPase activating protein 2a, transcript variant X5
RAP1 GTPase activating protein 2a, transcript variant X4
rap1 GTPase-activating protein 2a isoform X4
RAP1 GTPase activating protein 2a, transcript variant X3
rap1 GTPase-activating protein 2a isoform X3
RAP1 GTPase activating protein 2a, transcript variant X7
RAP1 GTPase activating protein 2a, transcript variant X8
RAP1 GTPase activating protein 2a, transcript variant X6
RAP1 GTPase activating protein 2a, transcript variant X2
rap1 GTPase-activating protein 2a isoform X2
rap1 GTPase-activating protein 2a isoform X5
RAP1 GTPase activating protein 2a, transcript variant X11
RAP1 GTPase activating protein 2a, transcript variant X9
RAP1 GTPase activating protein 2a, transcript variant X10
rap1 GTPase-activating protein 2a isoform X6
dehydrogenase/reductase (SDR family) member 13b.2, transcript variant X3
dehydrogenase/reductase (SDR family) member 13b.2, transcript variant X2
dehydrogenase/reductase (SDR family) member 13b.2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
vacuolar protein sorting-associated protein 53 homolog
ceramide synthase-like, transcript variant X1
ceramide synthase-like, transcript variant X2
ceramide synthase-like, transcript variant X3
gem (nuclear organelle) associated protein 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
gem (nuclear organelle) associated protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
gem (nuclear organelle) associated protein 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
gem (nuclear organelle) associated protein 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
gem (nuclear organelle) associated protein 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
gem (nuclear organelle) associated protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
CUE domain containing 1b, transcript variant X1
CUE domain containing 1b, transcript variant X2
vascular endothelial zinc finger 1-like, transcript variant X3
vascular endothelial zinc finger 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
vascular endothelial zinc finger 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
vascular endothelial zinc finger 1-like isoform X2
vascular endothelial zinc finger 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
vascular endothelial zinc finger 1-like isoform X3
vascular endothelial zinc finger 1-like isoform X1
dynein light chain 2, cytoplasmic, transcript variant X2
dynein light chain 2, cytoplasmic, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
hepatocyte nuclear factor 1-beta-A isoform X3
hepatocyte nuclear factor 1-beta-A isoform X1
hepatocyte nuclear factor 1-beta-A isoform X5
hepatocyte nuclear factor 1-beta-A isoform X2
hepatocyte nuclear factor 1-beta-A isoform X6
hepatocyte nuclear factor 1-beta-A isoform X4
hepatocyte nuclear factor 1-beta-A isoform X7
DEAD (Asp-Glu-Ala-Asp) box polypeptide 52
probable ATP-dependent RNA helicase DDX52
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dual specificity phosphatase 14, transcript variant X2
dual specificity phosphatase 14, transcript variant X1
transcriptional adaptor 2A, transcript variant X1
transcriptional adaptor 2A, transcript variant X2
transcriptional adapter 2-alpha isoform X2
transcriptional adapter 2-alpha isoform X1
nuclear pore membrane glycoprotein 210-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear pore membrane glycoprotein 210-like, transcript variant X5
nuclear pore membrane glycoprotein 210-like, transcript variant X2
nuclear pore membrane glycoprotein 210-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear pore membrane glycoprotein 210-like, transcript variant X4
nuclear pore membrane glycoprotein 210-like, transcript variant X7
nuclear pore membrane glycoprotein 210-like, transcript variant X9
nuclear pore membrane glycoprotein 210-like isoform X3
nuclear pore membrane glycoprotein 210-like isoform X5
nuclear pore membrane glycoprotein 210-like isoform X2
nuclear pore membrane glycoprotein 210-like isoform X1
nuclear pore membrane glycoprotein 210-like isoform X4
nuclear pore membrane glycoprotein 210-like isoform X7
nuclear pore membrane glycoprotein 210-like isoform X9
nuclear pore membrane glycoprotein 210-like, transcript variant X6
nuclear pore membrane glycoprotein 210-like isoform X6
nuclear pore membrane glycoprotein 210-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear pore membrane glycoprotein 210-like isoform X8
NIMA-related kinase 8, transcript variant X1
NIMA-related kinase 8, transcript variant X3
NIMA-related kinase 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NIMA-related kinase 8, transcript variant X2
NIMA-related kinase 8, transcript variant X5
uncharacterized LOC122563822, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122563822, transcript variant X1
uncharacterized LOC122563822, transcript variant X3
uncharacterized protein LOC122563822 isoform X2
uncharacterized protein LOC122563822 isoform X1
uncharacterized protein LOC122563822 isoform X3
carboxypeptidase D-like, transcript variant X2
carboxypeptidase D-like, transcript variant X1
golgi SNAP receptor complex member 1, transcript variant X1
golgi SNAP receptor complex member 1, transcript variant X2
Golgi SNAP receptor complex member 1 isoform X1
Golgi SNAP receptor complex member 1 isoform X2
golgi SNAP receptor complex member 1, transcript variant X3
Golgi SNAP receptor complex member 1 isoform X3
trafficking regulator of GLUT4 (SLC2A4) 1a
class A basic helix-loop-helix protein 9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear fragile X mental retardation-interacting protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
armadillo repeat-containing protein 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
G protein-coupled receptor kinase interacting ArfGAP 1
ankyrin repeat domain 13B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ankyrin repeat domain 13B, transcript variant X1
ankyrin repeat domain 13B, transcript variant X2
ankyrin repeat domain-containing protein 13B isoform X1
ankyrin repeat domain-containing protein 13B isoform X2
ankyrin repeat domain-containing protein 13B isoform X3
slingshot protein phosphatase 2a, transcript variant X4
slingshot protein phosphatase 2a, transcript variant X3
slingshot protein phosphatase 2a, transcript variant X2
slingshot protein phosphatase 2a, transcript variant X1
slingshot protein phosphatase 2a, transcript variant X5
protein phosphatase Slingshot homolog 2 isoform X4
protein phosphatase Slingshot homolog 2 isoform X3
protein phosphatase Slingshot homolog 2 isoform X2
protein phosphatase Slingshot homolog 2 isoform X1
protein phosphatase Slingshot homolog 2 isoform X5
EF-hand calcium-binding domain-containing protein 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear speckle splicing regulatory protein 1
sodium-dependent serotonin transporter-like, transcript variant X1
sodium-dependent serotonin transporter-like, transcript variant X3
sodium-dependent serotonin transporter-like, transcript variant X2
sodium-dependent serotonin transporter-like isoform X1
sodium-dependent serotonin transporter-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sodium-dependent serotonin transporter-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sodium-dependent serotonin transporter-like isoform X2
transmembrane and immunoglobulin domain containing 1
transmembrane and immunoglobulin domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122564014, transcript variant X1
uncharacterized LOC122564014, transcript variant X3
uncharacterized LOC122564014, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
unconventional myosin-XVIIIa isoform X14
unconventional myosin-XVIIIa isoform X10
unconventional myosin-XVIIIa isoform X12
unconventional myosin-XVIIIa isoform X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
unconventional myosin-XVIIIa isoform X11
unconventional myosin-XVIIIa isoform X13
unconventional myosin-XVIIIa isoform X16
unconventional myosin-XVIIIa isoform X15
pipecolic acid oxidase, transcript variant X1
pipecolic acid oxidase, transcript variant X2
peroxisomal sarcosine oxidase isoform X1
peroxisomal sarcosine oxidase isoform X2
seizure related 6 homolog b, transcript variant X3
seizure related 6 homolog b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
seizure related 6 homolog b, transcript variant X2
PHD finger protein 12b, transcript variant X1
PHD finger protein 12b, transcript variant X2
dehydrogenase/reductase SDR family member 13-like
zinc finger and BTB domain-containing protein 11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 11-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 11-like isoform X1
zinc finger and BTB domain-containing protein 11-like isoform X2
zinc finger and BTB domain-containing protein 11-like, transcript variant X3
zinc finger and BTB domain-containing protein 11-like isoform X3
acetyl-CoA carboxylase alpha, transcript variant X1
acetyl-CoA carboxylase alpha, transcript variant X2
apoptosis antagonizing transcription factor
LIM/homeobox protein Lhx1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LIM/homeobox protein Lhx1-like, transcript variant X2
LIM/homeobox protein Lhx1-like, transcript variant X1
LIM/homeobox protein Lhx1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
LIM/homeobox protein Lhx1-like isoform X2
LIM/homeobox protein Lhx1-like isoform X1
uncharacterized LOC122564026, transcript variant X1
uncharacterized LOC122564026, transcript variant X2
mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae), transcript variant X1
mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae), transcript variant X2
rRNA methyltransferase 1, mitochondrial isoform X1
rRNA methyltransferase 1, mitochondrial isoform X2
mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
rRNA methyltransferase 1, mitochondrial isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00150
COORDINATES: nucleotide motif:Rfam:12.0:RF00266
RAB34, member RAS oncogene family a, transcript variant X1
RAB34, member RAS oncogene family a, transcript variant X2
uncharacterized protein LOC100126024 homolog, transcript variant X1
uncharacterized protein LOC100126024 homolog, transcript variant X2
adenine phosphoribosyltransferase isoform X1
adenine phosphoribosyltransferase isoform X2
SPT6 homolog, histone chaperone and transcription elongation factor, transcript variant X1
SPT6 homolog, histone chaperone and transcription elongation factor, transcript variant X2
SPT6 homolog, histone chaperone and transcription elongation factor, transcript variant X3
transcription elongation factor SPT6 isoform X2
transcription elongation factor SPT6 isoform X1
transcription elongation factor SPT6 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00566
WSC domain-containing protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WSC domain-containing protein 1-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
WSC domain-containing protein 1-like, transcript variant X2
WSC domain-containing protein 1-like, transcript variant X1
WSC domain-containing protein 1-like, transcript variant X9
WSC domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
WSC domain-containing protein 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WSC domain-containing protein 1-like, transcript variant X5
WSC domain-containing protein 1-like, transcript variant X7
WSC domain-containing protein 1-like isoform X1
WSC domain-containing protein 1-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
aryl hydrocarbon receptor interacting protein-like 1
aryl-hydrocarbon-interacting protein-like 1
uncharacterized LOC122564038, transcript variant X1
uncharacterized LOC122564038, transcript variant X2
protein PIMREG-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein PIMREG-like, transcript variant X3
protein PIMREG-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PITPNM family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PITPNM family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PITPNM family member 3, transcript variant X2
membrane-associated phosphatidylinositol transfer protein 3 isoform X3
membrane-associated phosphatidylinositol transfer protein 3 isoform X1
membrane-associated phosphatidylinositol transfer protein 3 isoform X2
thioredoxin domain-containing protein 17
Rab interacting lysosomal protein, transcript variant X2
Rab interacting lysosomal protein, transcript variant X4
Rab interacting lysosomal protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Rab interacting lysosomal protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transfer RNA threonine (anticodon CGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
pre-mRNA processing factor 8, transcript variant X2
pre-mRNA processing factor 8, transcript variant X1
pre-mRNA-processing-splicing factor 8 isoform X1
pre-mRNA-processing-splicing factor 8 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78% coverage of the annotated genomic feature by RNAseq alignments
apoptosis inducing factor mitochondria associated 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
apoptosis inducing factor mitochondria associated 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
apoptosis inducing factor mitochondria associated 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
apoptosis inducing factor mitochondria associated 4, transcript variant X4
apoptosis inducing factor mitochondria associated 4 isoform X1
apoptosis inducing factor mitochondria associated 4 isoform X2
apoptosis inducing factor mitochondria associated 4 isoform X3
uncharacterized LOC122564047, transcript variant X2
uncharacterized LOC122564047, transcript variant X1
amyloid beta precursor protein (cytoplasmic tail) binding protein 2, transcript variant X1
amyloid beta precursor protein (cytoplasmic tail) binding protein 2, transcript variant X2
amyloid protein-binding protein 2 isoform X2
amyloid protein-binding protein 2 isoform X1
uncharacterized protein si:ch1073-145m9.1
ubiquitin specific peptidase 32, transcript variant X1
ubiquitin specific peptidase 32, transcript variant X2
ubiquitin specific peptidase 32, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 32 isoform X1
ubiquitin carboxyl-terminal hydrolase 32 isoform X2
ubiquitin carboxyl-terminal hydrolase 32 isoform X3
ubiquitin specific peptidase 32, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 32 isoform X4
calcitonin gene-related peptide-receptor component protein
DNA-directed RNA polymerase III subunit RPC9
protein-tyrosine sulfotransferase 1-like, transcript variant X1
protein-tyrosine sulfotransferase 1-like, transcript variant X3
protein-tyrosine sulfotransferase 1-like, transcript variant X4
protein-tyrosine sulfotransferase 1-like, transcript variant X2
protein-tyrosine sulfotransferase 1-like isoform X2
protein-tyrosine sulfotransferase 1-like isoform X3
protein-tyrosine sulfotransferase 1-like isoform X1
potassium channel tetramerization domain containing 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD7 isoform X1
potassium channel tetramerization domain containing 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD7 isoform X2
RAB guanine nucleotide exchange factor (GEF) 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RAB guanine nucleotide exchange factor (GEF) 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
RAB guanine nucleotide exchange factor (GEF) 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
RAB guanine nucleotide exchange factor (GEF) 1, transcript variant X4
transmembrane protein 248, transcript variant X1
transmembrane protein 248, transcript variant X2
rab effector Noc2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
rab effector Noc2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
rab effector Noc2-like, transcript variant X1
rab effector Noc2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
rab effector Noc2-like, transcript variant X4
double C2-like domain-containing protein beta, transcript variant X1
double C2-like domain-containing protein beta, transcript variant X2
double C2-like domain-containing protein beta isoform X1
double C2-like domain-containing protein beta isoform X2
sodium- and chloride-dependent GABA transporter 1, transcript variant X1
sodium- and chloride-dependent GABA transporter 1 isoform X1
sodium- and chloride-dependent GABA transporter 1, transcript variant X2
sodium- and chloride-dependent GABA transporter 1 isoform X2
dehydrogenase/reductase 11a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
dehydrogenase/reductase 11a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
dehydrogenase/reductase 11a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dehydrogenase/reductase SDR family member 11a isoform X1
dehydrogenase/reductase SDR family member 11a isoform X2
dehydrogenase/reductase SDR family member 11a isoform X3
gametogenetin binding protein 2, transcript variant X2
gametogenetin binding protein 2, transcript variant X1
gametogenetin-binding protein 2 isoform X2
gametogenetin-binding protein 2 isoform X1
phosphatidylinositol glycan anchor biosynthesis, class W
phosphatidylinositol-glycan biosynthesis class W protein
unconventional myosin-XIX, transcript variant X1
unconventional myosin-XIX, transcript variant X2
unconventional myosin-XIX, transcript variant X3
zinc finger, HIT-type containing 3, transcript variant X5
zinc finger, HIT-type containing 3, transcript variant X3
zinc finger, HIT-type containing 3, transcript variant X2
zinc finger, HIT-type containing 3, transcript variant X4
zinc finger, HIT-type containing 3, transcript variant X1
zinc finger, HIT-type containing 3, transcript variant X7
zinc finger, HIT-type containing 3, transcript variant X6
zinc finger HIT domain-containing protein 3 isoform X5
zinc finger HIT domain-containing protein 3 isoform X3
zinc finger HIT domain-containing protein 3 isoform X2
zinc finger HIT domain-containing protein 3 isoform X4
zinc finger HIT domain-containing protein 3 isoform X1
zinc finger HIT domain-containing protein 3 isoform X7
zinc finger HIT domain-containing protein 3 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
uncharacterized LOC122564071, transcript variant X2
uncharacterized LOC122564071, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
vitamin K epoxide reductase complex, subunit 1-like 1
vitamin K epoxide reductase complex subunit 1-like protein 1
cytosolic arginine sensor for mTORC1 subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
uncharacterized LOC122564078, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC122564078, transcript variant X4
uncharacterized LOC122564078, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC122564078, transcript variant X1
uncharacterized LOC122564078, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00393
COORDINATES: nucleotide motif:Rfam:12.0:RF00425
TATA box-binding protein-associated factor RNA polymerase I subunit D-like, transcript variant X5
TATA box-binding protein-associated factor RNA polymerase I subunit D-like, transcript variant X3
TATA box-binding protein-associated factor RNA polymerase I subunit D-like, transcript variant X1
TATA box-binding protein-associated factor RNA polymerase I subunit D-like, transcript variant X2
TATA box-binding protein-associated factor RNA polymerase I subunit D-like, transcript variant X4
TATA box-binding protein-associated factor RNA polymerase I subunit D-like isoform X1
TATA box-binding protein-associated factor RNA polymerase I subunit D-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
TATA box-binding protein-associated factor RNA polymerase I subunit D-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
TATA box-binding protein-associated factor RNA polymerase I subunit D-like isoform X2
chromosome 28 C11orf54 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
chromosome 28 C11orf54 homolog, transcript variant X2
chromosome 28 C11orf54 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
chromosome 28 C11orf54 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ester hydrolase C11orf54 homolog isoform X1
ester hydrolase C11orf54 homolog isoform X3
chromosome 28 C11orf54 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromosome 28 C11orf54 homolog, transcript variant X4
ester hydrolase C11orf54 homolog isoform X2
ester hydrolase C11orf54 homolog isoform X4
uncharacterized LOC122563829, transcript variant X2
uncharacterized LOC122563829, transcript variant X1
activator of transcription and developmental regulator AUTS2 a, transcript variant X9
autism susceptibility gene 2 protein isoform X8
activator of transcription and developmental regulator AUTS2 a, transcript variant X1
activator of transcription and developmental regulator AUTS2 a, transcript variant X7
activator of transcription and developmental regulator AUTS2 a, transcript variant X5
activator of transcription and developmental regulator AUTS2 a, transcript variant X4
activator of transcription and developmental regulator AUTS2 a, transcript variant X6
activator of transcription and developmental regulator AUTS2 a, transcript variant X3
activator of transcription and developmental regulator AUTS2 a, transcript variant X8
activator of transcription and developmental regulator AUTS2 a, transcript variant X2
autism susceptibility gene 2 protein isoform X1
autism susceptibility gene 2 protein isoform X6
autism susceptibility gene 2 protein isoform X4
autism susceptibility gene 2 protein isoform X3
autism susceptibility gene 2 protein isoform X5
autism susceptibility gene 2 protein isoform X2
autism susceptibility gene 2 protein isoform X7
activator of transcription and developmental regulator AUTS2 a, transcript variant X10
autism susceptibility gene 2 protein isoform X9
activator of transcription and developmental regulator AUTS2 a, transcript variant X11
autism susceptibility gene 2 protein isoform X10
polypeptide N-acetylgalactosaminyltransferase 17, transcript variant X3
polypeptide N-acetylgalactosaminyltransferase 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 17 isoform X1
polypeptide N-acetylgalactosaminyltransferase 17 isoform X3
polypeptide N-acetylgalactosaminyltransferase 17 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
tRNA-yW synthesizing protein 1 homolog (S. cerevisiae), transcript variant X2
tRNA-yW synthesizing protein 1 homolog (S. cerevisiae), transcript variant X1
S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 isoform X2
S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 isoform X1
tRNA-yW synthesizing protein 1 homolog (S. cerevisiae), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 isoform X3
neurofibromin 2b (merlin), transcript variant X2
neurofibromin 2b (merlin), transcript variant X1
neurofibromin 2b (merlin), transcript variant X3
28S ribosomal protein S17, mitochondrial
protein NipSnap homolog 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
protein NipSnap homolog 2-like, transcript variant X1
phosphoserine phosphatase, transcript variant X3
phosphoserine phosphatase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
phosphoserine phosphatase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium/glucose cotransporter 2 isoform X1
sodium/glucose cotransporter 2 isoform X2
transducin beta like 2, transcript variant X1
transducin beta like 2, transcript variant X2
transducin beta like 2, transcript variant X3
transducin beta-like protein 2 isoform X1
transducin beta-like protein 2 isoform X2
transducin beta-like protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: short-chain dehydrogenase srdF-like
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X6
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X7
peripheral-type benzodiazepine receptor-associated protein 1-like isoform X6
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X2
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X1
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X4
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X3
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X5
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X10
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X11
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X16
peripheral-type benzodiazepine receptor-associated protein 1-like isoform X1
peripheral-type benzodiazepine receptor-associated protein 1-like isoform X4
peripheral-type benzodiazepine receptor-associated protein 1-like isoform X12
peripheral-type benzodiazepine receptor-associated protein 1-like isoform X2
peripheral-type benzodiazepine receptor-associated protein 1-like isoform X3
peripheral-type benzodiazepine receptor-associated protein 1-like isoform X5
peripheral-type benzodiazepine receptor-associated protein 1-like isoform X9
peripheral-type benzodiazepine receptor-associated protein 1-like isoform X8
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X8
peripheral-type benzodiazepine receptor-associated protein 1-like isoform X7
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X13
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X14
peripheral-type benzodiazepine receptor-associated protein 1-like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
complement C1q tumor necrosis factor-related protein 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
eosinophil peroxidase-like, transcript variant X1
eosinophil peroxidase-like, transcript variant X2
SPT4 homolog, DSIF elongation factor subunit
heat shock transcription factor family member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
4-hydroxyphenylpyruvate dioxygenase a, transcript variant X2
4-hydroxyphenylpyruvate dioxygenase a, transcript variant X1
4-hydroxyphenylpyruvate dioxygenase isoform X2
4-hydroxyphenylpyruvate dioxygenase isoform X1
cytochrome b-c1 complex subunit 6, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 188 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
LIM domain kinase 1a, transcript variant X1
LIM domain kinase 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
VPS37D subunit of ESCRT-I, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
vacuolar protein sorting-associated protein 37D isoform X1
VPS37D subunit of ESCRT-I, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
VPS37D subunit of ESCRT-I, transcript variant X2
vacuolar protein sorting-associated protein 37D isoform X2
vacuolar protein sorting-associated protein 37D isoform X3
VPS37D subunit of ESCRT-I, transcript variant X4
B-cell CLL/lymphoma 7 protein family member B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
B-cell CLL/lymphoma 7 protein family member B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
B-cell CLL/lymphoma 7 protein family member B-like isoform X1
B-cell CLL/lymphoma 7 protein family member B-like isoform X2
MKS transition zone complex subunit 1, transcript variant X1
Meckel syndrome type 1 protein isoform X1
MKS transition zone complex subunit 1, transcript variant X2
Meckel syndrome type 1 protein isoform X2
bromodomain adjacent to zinc finger domain, 1B, transcript variant X1
bromodomain adjacent to zinc finger domain, 1B, transcript variant X2
tyrosine-protein kinase BAZ1B isoform X1
tyrosine-protein kinase BAZ1B isoform X2
bromodomain adjacent to zinc finger domain, 1B, transcript variant X3
tyrosine-protein kinase BAZ1B isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
inactive peptidyl-prolyl cis-trans isomerase FKBP6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 27% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC122564228
transmembrane protein 132E, transcript variant X2
transmembrane protein 132E, transcript variant X1
transmembrane protein 132E, transcript variant X3
huntingtin interacting protein 1, transcript variant X4
huntingtin interacting protein 1, transcript variant X1
huntingtin interacting protein 1, transcript variant X3
huntingtin interacting protein 1, transcript variant X2
huntingtin interacting protein 1, transcript variant X5
huntingtin-interacting protein 1 isoform X4
huntingtin-interacting protein 1 isoform X1
huntingtin-interacting protein 1 isoform X3
huntingtin-interacting protein 1 isoform X2
huntingtin-interacting protein 1 isoform X5
POM121 transmembrane nucleoporin, transcript variant X2
POM121 transmembrane nucleoporin, transcript variant X1
POM121 transmembrane nucleoporin, transcript variant X3
nuclear envelope pore membrane protein POM 121 isoform X1
nuclear envelope pore membrane protein POM 121 isoform X2
nuclear envelope pore membrane protein POM 121 isoform X3
POM121 transmembrane nucleoporin, transcript variant X4
nuclear envelope pore membrane protein POM 121 isoform X4
probable 28S rRNA (cytosine-C(5))-methyltransferase
ligase III, DNA, ATP-dependent, transcript variant X1
ligase III, DNA, ATP-dependent, transcript variant X2
ligase III, DNA, ATP-dependent, transcript variant X3
complement factor B-like, transcript variant X2
complement factor B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
DNA repair protein RAD51 homolog 4 isoform X2
DNA repair protein RAD51 homolog 4 isoform X1
CAP-GLY domain containing linker protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
CAP-Gly domain-containing linker protein 2
GTF2I repeat domain containing 1, transcript variant X5
GTF2I repeat domain containing 1, transcript variant X2
GTF2I repeat domain containing 1, transcript variant X1
GTF2I repeat domain containing 1, transcript variant X7
GTF2I repeat domain containing 1, transcript variant X4
GTF2I repeat domain containing 1, transcript variant X6
GTF2I repeat domain containing 1, transcript variant X3
general transcription factor II-I repeat domain-containing protein 1 isoform X1
general transcription factor II-I repeat domain-containing protein 1 isoform X3
general transcription factor II-I repeat domain-containing protein 1 isoform X5
general transcription factor II-I repeat domain-containing protein 1 isoform X2
general transcription factor II-I repeat domain-containing protein 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
deltex 2, E3 ubiquitin ligase, transcript variant X3
deltex 2, E3 ubiquitin ligase, transcript variant X2
deltex 2, E3 ubiquitin ligase, transcript variant X1
probable E3 ubiquitin-protein ligase DTX2 isoform X2
probable E3 ubiquitin-protein ligase DTX2 isoform X3
probable E3 ubiquitin-protein ligase DTX2 isoform X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 4
leucine-rich repeats and WD repeat domain containing 1, transcript variant X3
leucine-rich repeats and WD repeat domain containing 1, transcript variant X2
leucine-rich repeats and WD repeat domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
leucine-rich repeats and WD repeat domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine-rich repeats and WD repeat domain containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine-rich repeats and WD repeat domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
leucine-rich repeat and WD repeat-containing protein 1
branched chain ketoacid dehydrogenase kinase, transcript variant X1
branched chain ketoacid dehydrogenase kinase, transcript variant X3
branched chain ketoacid dehydrogenase kinase, transcript variant X2
3-methyl-2-oxobutanoate dehydrogenase [lipoamide] kinase, mitochondrial isoform X1
3-methyl-2-oxobutanoate dehydrogenase [lipoamide] kinase, mitochondrial isoform X3
3-methyl-2-oxobutanoate dehydrogenase [lipoamide] kinase, mitochondrial isoform X2
lysine-specific demethylase 2B-like, transcript variant X2
lysine-specific demethylase 2B-like, transcript variant X1
lysine-specific demethylase 2B-like, transcript variant X3
lysine-specific demethylase 2B-like isoform X3
lysine-specific demethylase 2B-like isoform X2
lysine-specific demethylase 2B-like isoform X1
ORAI calcium release-activated calcium modulator 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
ion channel TACAN-like, transcript variant X2
ion channel TACAN-like, transcript variant X1
NADPH--cytochrome P450 reductase-like, transcript variant X1
NADPH--cytochrome P450 reductase-like, transcript variant X5
NADPH--cytochrome P450 reductase-like, transcript variant X2
NADPH--cytochrome P450 reductase-like, transcript variant X6
NADPH--cytochrome P450 reductase-like, transcript variant X4
NADPH--cytochrome P450 reductase-like, transcript variant X3
NADPH--cytochrome P450 reductase-like isoform X1
NADPH--cytochrome P450 reductase-like isoform X2
NADPH--cytochrome P450 reductase-like isoform X4
NADPH--cytochrome P450 reductase-like isoform X3
NADPH--cytochrome P450 reductase-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 183 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 211 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cytochrome P450 2J6-like, transcript variant X2
cytochrome P450 2J6-like, transcript variant X1
microtubule-associated protein RP/EB family member 1-like
rhomboid domain-containing protein 2-like, transcript variant X1
rhomboid domain-containing protein 2-like
rhomboid domain-containing protein 2-like, transcript variant X2
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X5
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X6
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X4
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X1
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X2
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X3
TATA-binding protein-associated factor 2N isoform X1
TATA-binding protein-associated factor 2N isoform X2
TATA-binding protein-associated factor 2N isoform X3
TATA-binding protein-associated factor 2N isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ras-like protein family member 10B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ras-like protein family member 10B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ras-like protein family member 10B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ras-like protein family member 10B, transcript variant X3
ras-like protein family member 10B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
AP-2 complex subunit beta, transcript variant X2
AP-2 complex subunit beta, transcript variant X3
AP-2 complex subunit beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
scavenger receptor cysteine-rich domain-containing group B protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
heat shock protein, alpha-crystallin-related, 1
serine/arginine repetitive matrix 3, transcript variant X4
serine/arginine repetitive matrix 3, transcript variant X5
serine/arginine repetitive matrix 3, transcript variant X1
serine/arginine repetitive matrix 3, transcript variant X2
serine/arginine repetitive matrix 3, transcript variant X3
serine/arginine repetitive matrix 3, transcript variant X6
serine/arginine repetitive matrix protein 3 isoform X2
serine/arginine repetitive matrix protein 3 isoform X1
serine/arginine repetitive matrix protein 3 isoform X3
serine/arginine repetitive matrix 3, transcript variant X7
serine/arginine repetitive matrix protein 3 isoform X4
serine/arginine repetitive matrix 3, transcript variant X8
serine/arginine repetitive matrix protein 3 isoform X5
malate dehydrogenase 2, NAD (mitochondrial)
serine/threonine/tyrosine interacting-like 1
serine/threonine/tyrosine-interacting-like protein 1
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase, transcript variant X1
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase, transcript variant X3
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase, transcript variant X2
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase, transcript variant X4
replication factor C (activator 1) 2, transcript variant X1
replication factor C subunit 2 isoform X1
replication factor C (activator 1) 2, transcript variant X2
replication factor C subunit 2 isoform X2
linker for activation of T-cells family member 2-like, transcript variant X1
linker for activation of T-cells family member 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
linker for activation of T-cells family member 2-like isoform X1
linker for activation of T-cells family member 2-like isoform X2
eukaryotic translation initiation factor 4h
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00407
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2G 1a (UBC7 homolog, yeast), transcript variant X3
ubiquitin-conjugating enzyme E2G 1a (UBC7 homolog, yeast), transcript variant X1
ubiquitin-conjugating enzyme E2G 1a (UBC7 homolog, yeast), transcript variant X2
ankyrin repeat and FYVE domain containing 1, transcript variant X2
ankyrin repeat and FYVE domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ankyrin repeat and FYVE domain containing 1, transcript variant X1
ankyrin repeat and FYVE domain containing 1, transcript variant X4
putative cell agglutination protein pfl4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60% coverage of the annotated genomic feature by RNAseq alignments
zinc finger, ZZ-type with EF hand domain 1, transcript variant X1
zinc finger, ZZ-type with EF hand domain 1, transcript variant X3
zinc finger, ZZ-type with EF hand domain 1, transcript variant X2
zinc finger ZZ-type and EF-hand domain-containing protein 1 isoform X1
zinc finger ZZ-type and EF-hand domain-containing protein 1 isoform X3
zinc finger ZZ-type and EF-hand domain-containing protein 1 isoform X2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
sarcoplasmic/endoplasmic reticulum calcium ATPase 1
purinergic receptor P2X, ligand-gated ion channel, 1
calcium/calmodulin-dependent protein kinase kinase 1, alpha a, transcript variant X12
calcium/calmodulin-dependent protein kinase kinase 1, alpha a, transcript variant X7
calcium/calmodulin-dependent protein kinase kinase 1, alpha a, transcript variant X11
calcium/calmodulin-dependent protein kinase kinase 1, alpha a, transcript variant X8
calcium/calmodulin-dependent protein kinase kinase 1, alpha a, transcript variant X4
calcium/calmodulin-dependent protein kinase kinase 1, alpha a, transcript variant X10
calcium/calmodulin-dependent protein kinase kinase 1, alpha a, transcript variant X1
calcium/calmodulin-dependent protein kinase kinase 1, alpha a, transcript variant X3
calcium/calmodulin-dependent protein kinase kinase 1, alpha a, transcript variant X5
calcium/calmodulin-dependent protein kinase kinase 1, alpha a, transcript variant X2
calcium/calmodulin-dependent protein kinase kinase 1, alpha a, transcript variant X6
calcium/calmodulin-dependent protein kinase kinase 1, alpha a, transcript variant X9
calcium/calmodulin-dependent protein kinase kinase 1, alpha a, transcript variant X13
calcium/calmodulin-dependent protein kinase kinase 1 isoform X3
calcium/calmodulin-dependent protein kinase kinase 1 isoform X2
calcium/calmodulin-dependent protein kinase kinase 1 isoform X1
calcium/calmodulin-dependent protein kinase kinase 1 isoform X4
RPA interacting protein, transcript variant X1
RPA interacting protein, transcript variant X2
aurora kinase B-B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
aurora kinase B-B-like, transcript variant X2
rabaptin, RAB GTPase binding effector protein 1, transcript variant X5
rabaptin, RAB GTPase binding effector protein 1, transcript variant X4
rabaptin, RAB GTPase binding effector protein 1, transcript variant X2
rabaptin, RAB GTPase binding effector protein 1, transcript variant X1
rabaptin, RAB GTPase binding effector protein 1, transcript variant X3
rab GTPase-binding effector protein 1 isoform X5
rab GTPase-binding effector protein 1 isoform X4
rab GTPase-binding effector protein 1 isoform X2
rab GTPase-binding effector protein 1 isoform X1
rab GTPase-binding effector protein 1 isoform X3
neutrophil cytosolic factor 1, transcript variant X1
neutrophil cytosolic factor 1, transcript variant X2
neutrophil cytosolic factor 1, transcript variant X3
neutrophil cytosolic factor 1, transcript variant X6
neutrophil cytosolic factor 1, transcript variant X4
neutrophil cytosolic factor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
myosin regulatory light chain 2, ventricular/cardiac muscle isoform-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein CASP-like, transcript variant X1
protein CASP-like, transcript variant X2
protein CASP-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein CASP-like, transcript variant X4
protein CASP-like, transcript variant X5
SH2B adapter protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
SH2B adapter protein 2, transcript variant X2
SH2B adapter protein 2, transcript variant X1
SH2B adapter protein 2, transcript variant X4
SH2B adapter protein 2, transcript variant X3
SH2B adapter protein 2, transcript variant X5
intraflagellar transport 22 homolog (Chlamydomonas), transcript variant X1
intraflagellar transport 22 homolog (Chlamydomonas), transcript variant X3
intraflagellar transport 22 homolog (Chlamydomonas), transcript variant X6
intraflagellar transport 22 homolog (Chlamydomonas), transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
intraflagellar transport protein 22 homolog isoform X1
intraflagellar transport protein 22 homolog isoform X3
intraflagellar transport protein 22 homolog isoform X6
intraflagellar transport protein 22 homolog isoform X5
intraflagellar transport 22 homolog (Chlamydomonas), transcript variant X2
intraflagellar transport protein 22 homolog isoform X2
intraflagellar transport 22 homolog (Chlamydomonas), transcript variant X4
intraflagellar transport protein 22 homolog isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
RCC1-like G exchanging factor-like protein
carbohydrate-responsive element-binding protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
DEAH (Asp-Glu-Ala-His) box polypeptide 33
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
chaperonin containing TCP1, subunit 6A (zeta 1)
COORDINATES: nucleotide motif:Rfam:12.0:RF00398
inactive C-alpha-formylglycine-generating enzyme 2
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform-like
sodium-dependent neutral amino acid transporter SLC6A17-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily C member 1-like
solute carrier family 16 member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
monocarboxylate transporter 5 isoform X1
solute carrier family 16 member 4, transcript variant X2
monocarboxylate transporter 5 isoform X2
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5